Inovio Pharmaceuticals

Inovio Pharmaceuticals, Inc. is an American biotechnology company based in Plymouth Meeting, Pennsylvania.

The company was founded on June 29, 1983 as Biotechnologies & Experimental Research, Inc.¹⁾ On December 10, 1991, the company changed its corporate name to BTX, Inc.

On February 8, 1994, the company changed its name to Genetronics. It went public in April 1994 by exchanging shares with Consolidated United Safety Technologies, which was listed on the Vancouver Stock Exchange in British Columbia, Canada.²⁾ On September 2, 1997, the company listed on the Toronto Stock Exchange (TSX). On December 8, 1998, the company listed on the American Stock Exchange and voluntarily de-listed from the TSX on January 17, 2003.

The company's focus during much of its early period as a U.S. stock was on electroporation, a technology for introducing DNA and drugs into cells through a brief electrical pulse that causes tiny pores to open in the cell membrane. Genetronics developed drug delivery systems using electroporation and sold electroporation equipment to the research laboratory market.

On June 15, 2001, Genetronics Biomedical Ltd. completed a change in jurisdiction of incorporation from British Columbia, Canada, to the state of Delaware and became Genetronics Biomedical Corporation. On January 25, 2005, Genetronics Biomedical Corporation acquired Inovio AS, a gene delivery technology company located in Norway.

On March 31, 2005, Genetronics Biomedical Corporation was renamed Inovio Biomedical Corporation.

On June 1, 2009, Inovio Biomedical merged with VGX Pharmaceuticals. On May 14, 2010, the combined entity changed its corporate name to Inovio Pharmaceuticals, Inc.

Inovio is a member company of the Biotechnology Innovation Organization (BIO).³⁾

• Housatonic
• Wikipedia